学科与关键词
关键词
homoharringtoninevenetoclaxrelapsed/refractoryacute myeloid leukemiagenetic pattern
- Influence of Molecular Abnormalities on Treatment Response of Venetoclax Plus Azacytidine and Homoharringtonine Versus Venetoclax Plus Hypomethylating Agent in Relapsed/Refractory Acute Myeloid LeukemiaYu, Guopan; Yin, Zhao; Jin, Hua; Yu, Sijian; Li, Yuhua; Nie, Danian; Guo, Ziwen; Sun, Zhiqiang; Meng, Qingxiang; Zhao, Weihua; Lin, Dongjun; Xu, Na; Zhang, Yu64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), New Orleans, LA, 2022-12-10 To 2022-12-13.被引 3
- Homoharringtonine Enhances the Anti-Leukemia Effect of Venetoclax in Acute Myeloid Leukemia with t(8;21)(q22;q22) Via Regulation of c-Myc/Bim AxisYu, Guopan; Yin, Zhao; Yao, Zurong; Nie, Xiaqi; Jin, Hua; Zhang, Yu; Xu, Dan; Jiang, Xuejie; Ping, Baohong65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
- Comparison of Two Venetoclax-Based Regimens As Salvage Therapies Bridged to Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid LeukemiaYe, Yiling; Chen, Yanqiu; Yu, Guopan; Weng, Guangyang; Liu, Qifa; Jin, Hua65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
